Lanean...
Predicting Disease Progression After Regional Therapy for In-Transit Melanoma
IMPORTANCE: Although approximately 30% to 50% of patients experience a complete response after regional chemotherapy for in-transit melanoma, a subset of patients will develop rapidly progressive disease. In the current era of an expanding armamentarium, including both regional and systemic options...
Gorde:
| Argitaratua izan da: | JAMA Surg |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161094/ https://ncbi.nlm.nih.gov/pubmed/23558401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2013.695 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|